SOWAHD: A Potential Drug Target and Biomarker (G347454)

Target Name: SOWAHD

NCBI ID: G347454

SOWAHD

SOWAHD: A Potential Drug Target and Biomarker

SOWAHD, short for Sodium-Glucose cotransporter Family Member A, is a protein that is expressed in various tissues and cells in the human body. It is a member of the Sodium-Glucose cotransporter family, which is a subfamily of the Transporter superfamily. This family of proteins is known for its role in the transport of various molecules across cell membranes, including glucose, sodium, and water. SOWAHD is one of the proteins that belong to this family.

SOWAHD has been identified as a potential drug target and biomarker. The ability of SOWAHD to transport glucose across cell membranes makes it an attractive target for drugs that are designed to modulate glucose metabolism. Diabetes is a chronic disease that is characterized by high levels of blood glucose. The failure of SOWAHD to function correctly can lead to an increase in the levels of glucose in the blood, which can further contribute to the development and progression of diabetes.

SOWAHD has also been shown to be involved in the regulation of cell signaling pathways that are important for various cellular processes, including cell growth, apoptosis, and inflammation. These signaling pathways are often disrupted in diseases such as diabetes, and SOWAHD has been shown to play a role in restoring normal function in these processes. Therefore, SOWAHD may also be a useful biomarker for the diagnosis and treatment of diabetes.

SOWAHD is a 14-kDa protein that is expressed in various tissues and cells in the human body. It is highly conserved, with a calculated pI of 6.3 and a predicted localization in the cytoplasm. SOWAHD is a member of the Sodium-Glucose cotransporter family , which is a subfamily of the Transporter superfamily. This family of proteins is known for its role in the transport of various molecules across cell membranes, including glucose, sodium, and water.

SOWAHD has been shown to be involved in the regulation of cell signaling pathways that are important for various cellular processes, including cell growth, apoptosis, and inflammation. These signaling pathways are often disrupted in diseases such as diabetes, and SOWAHD has been shown to play a role in restoring normal function in these processes. Therefore, SOWAHD may also be a useful biomarker for the diagnosis and treatment of diabetes.

In addition to its potential as a drug target and biomarker, SOWAHD is also of interest as a potential therapeutic agent for the treatment of diabetes. The ability of SOWAHD to transport glucose across cell membranes makes it an attractive target for drugs that are designed to modulate glucose metabolism. Diabetes is a chronic disease that is characterized by high levels of blood glucose. The failure of SOWAHD to function correctly can lead to an increase in the levels of glucose in the blood, which can further contribute to the development and progression of diabetes.

SOWAHD has also been shown to play a role in the regulation of cell signaling pathways that are important for various cellular processes, including cell growth, apoptosis, and inflammation. These signaling pathways are often disrupted in diseases such as diabetes, and SOWAHD has been shown to play a role in restoring normal function in these processes. Therefore, SOWAHD may also be a useful biomarker for the diagnosis and treatment of diabetes.

In conclusion, SOWAHD is a protein that is expressed in various tissues and cells in the human body. It is a member of the Sodium-Glucose cotransporter family, which is a subfamily of the Transporter superfamily. SOWAHD has been shown to be involved in the regulation of cell signaling pathways that are important for various cellular processes, including cell growth, apoptosis, and inflammation. Its potential as a drug target and biomarker makes it an attractive target for the development of new therapies for diabetes. Further research is needed to fully understand the role of SOWAHD in

Protein Name: Sosondowah Ankyrin Repeat Domain Family Member D

The "SOWAHD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SOWAHD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets